What happened
REDUCE trial evaluates spironolactone-based blood pressure management after stroke, with clinical results pending.
Why the trial, key points, tables, limitations, PICO, abstract, media & sources
Expert reaction
AHA Scientific Sessions 2026
0 experts have reacted so far. We show the split once 3 have.
Expert labels are toward REDUCE's result, from named public quotes (n=0). As of Oct 22, 2026.
A randomized controlled trial of spironolactone-based blood pressure management after stroke (REDUCE)
A randomized controlled trial of spironolactone-based blood pressure management after stroke (REDUCE). Session: LBS.02. Late-breaking trial at AHA Scientific Sessions 2026. Results pending.
No takes yet. Share an insight, caveat, or question.
Brigger et al. (2026) studied this question. Spironolactone-based blood pressure management after stroke is being evaluated in the REDUCE randomized controlled trial, with clinical results currently pending.